Gene · 5205
Papers1,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer. | Adv Ther | 2023 | 37462865 | PubTator, text mining | PubMed |
| RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer. | Breast Cancer Res | 2023 | 37461077 | PubTator, text mining | PubMed |
| Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis. | JHEP Rep | 2023 | 37456676 | PubTator, text mining | PubMed |
| Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy. | J Clin Med | 2023 | 37445442 | PubTator, text mining | PubMed |
| Reconstitution of ATP-dependent lipid transporters: gaining insight into molecular characteristics, regulation, and mechanisms. | Biosci Rep | 2023 | 37417269 | PubTator, text mining | PubMed |
Optimal liver transplant procedure in progressive familial intrahepatic cholestasis type 1 treated with biliary diversion or intestinal transplantation: Lessons learned from three cases treated with different approaches. | Pediatr Transplant | 2023 | 37417206 | PubTator, text mining | PubMed |
| Proteomic Comparison of Paraspinal Muscle Imbalance Between Idiopathic Scoliosis and Congenital Scoliosis. | Neurospine | 2023 | 37401090 | PubTator, text mining | PubMed |
| A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer. | ESMO Open | 2023 | 37393630 | PubTator, text mining | PubMed |
| Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness. | Sci Adv | 2023 | 37390209 | PubTator, text mining | PubMed |
| COmic: convolutional kernel networks for interpretable end-to-end learning on (multi-)omics data. | Bioinformatics | 2023 | 37387152 | PubTator, text mining | PubMed |
| In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated Breast Cancers. | Int J Mol Sci | 2023 | 37373065 | PubTator, text mining | PubMed |
| Surgical versus Medical Management of Progressive Familial Intrahepatic Cholestasis-Case Compilation and Review of the Literature. | Children (Basel) | 2023 | 37371180 | PubTator, text mining | PubMed |
| Progressive familial intrahepatic cholestasis-outcome and time to transplant after biliary diversion according to genetic subtypes. | Front Surg | 2023 | 37361697 | PubTator, text mining | PubMed |
| Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis. | Front Pharmacol | 2023 | 37324459 | PubTator, text mining | PubMed |
| Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer. | Ann Surg | 2023 | 37318852 | PubTator, text mining | PubMed |
| Heterogeneity in biomarkers, mitogenome and genetic disorders of the Arab population with special emphasis on large-scale whole-exome sequencing. | Arch Med Sci | 2023 | 37313193 | PubTator, text mining | PubMed |
| Infiltrating myeloid cell diversity determines oncological characteristics and clinical outcomes in breast cancer. | Breast Cancer Res | 2023 | 37287069 | PubTator, text mining | PubMed |
| Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer. | J Exp Clin Cancer Res | 2023 | 37280675 | PubTator, text mining | PubMed |
| Systematic review: efficacy of therapies for cholestatic pruritus. | Ther Adv Gastroenterol | 2023 | 37255856 | PubTator, text mining | PubMed |
| MRGCN: cancer subtyping with multi-reconstruction graph convolutional network using full and partial multi-omics dataset. | Bioinformatics | 2023 | 37255323 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5205/papers?page=11